Chesapeake Energy beats and then shares drop–it’s tough being a natural gas stock right now
There’s really nothing wrong with Chesapeake Energy (CHK) that an increase in natural gas prices wouldn’t fix. Yesterday, August 3, Chesapeake reported second quarter earnings of 18 cents a share after subtracting one-time events. In the second quarter of...
Xylem raises guidance for fiscal 2017 after slight earnings beat in second quarter
On August 1 Xylem (XYL) reported second quarter earnings of 59 cents a share (excluding one-time items), beating Wall Street earnings estimates by 2 cents a share. Thanks to recent acquisitions revenue of $1.16 billion climbed 24.9% year over year, slightly missing...
Apple earnings solid enough to support tech sector
The big questions for Apple (AAPL) won’t be answered until this fall when investors get to see the new iPhone (and see how hot or not it is) and learn whether or not Apple’s suppliers are indeed having trouble manufacturing key components such as the OLED...
What happened in the markets (and economy) last week–and what it means for August and September
Let’s try to put together a few events from last week into a coherent (or, if that’s too much to hope, at least a semi-coherent) explanation for where the equity market stands now. What events, you ask? How about Friday’s report on second quarter GDP...
Long-term pick Bunge gets motivated
“Depend upon it, sir, when a man knows he is to be hanged in a fortnight, it concentrates his mind wonderfully,” James Boswell quotes Samuel Johnson as saying upon the occasion of the hanging of William Dodd in 1777 for a loan scam. CEOs don’t...
Huge earnings beat can’t save Alphabet from metrics miss
Alphabet (GOOG) dropped 3.1% in after hours trading in spite of reporting earnings of $5.01 a share, well ahead of the $4.49 expected by Wall Street. Revenue of $26.01 billion, up 21% from the second quarter of 2016, also beat the Wall Street consensus of $25.6...
MGM shares climb on news stock is to join S&P 500
Effective July 26, MGM Resorts International (MGM) will join the Standard & Poor’s 500 stock index to replace Reynolds American (RAI), which is being acquired by British American Tobacco. (That means that all funds that track the S&P 500 index will...
Qualcomm’s earnings show cash flow under siege; selling out of Dividend Portfolio
The earnings Qualcomm (QCOM) reported yesterday, July 19, were okay. Earnings of 83 cents a share for the June quarter, in fact, beat the Wall Street consensus by two cents a share. Revenue of $5.37 billion was ahead of analyst projections of $5.25 billion, but still...
Good news on two fronts from dividend pick Kinder Morgan
Yesterday, July 19, Kinder Morgan (KMI) reported earnings per share of 15 cents, in line with Wall Street expectations. Revenues of $3.37 billion were ahead of the consensus estimate of $3.12 billion and represented year over year growth of 7.1%. Â That was item one...
Adding Nidec (NJDCY) to my long-term 50 stocks portfolio
Back on July 11 I wrote a Sector Monday post on the robotics sector on my subscription site JubakAM.com. I’ve already added Fanuc (FANUY) to my long-term 50 Stocks portfolio. And tomorrow with this post I will be adding Nidec (NJDCY) to that same long-term...
Buy Fanuc in my long-term 50 Stocks portfolio
I’m adding the ADRs for Japan’s Facuc (FANUY:US) to my long-term 50 Stocks portfolio today, July 13. If you’re looking for a stock to take advantage of the long-term growth in the more conventional end of the robotics sector, I think Fanuc is your...
One less worry hanging over shares of Jubak Pick Cheniere Energy
One worry hanging over shares of Cheniere Energy (LNG), the first company to get an unrestricted license to export liquified natural gas (LNG) to any country in the world, was what would happen if some of the customers that signed a long-term contract to buy LNG from...
HAIN spikes 8.56% on news that an activist investor is pressing the company to sell itself
I’ve been waiting for this for more than a year. And so have a lot of other investors and traders from the market reaction today. Shares of Hain Celestial Group (HAIN) jumped 8.56% today on news that activist investor Engaged Capital had accumulated almost 10%...
Visa: It you can’t beat ’em, buy ’em
Visa (V) is defending its turf in the financial processing market by buying and/or partnering with the new generation of fintech companies. Visa’s latest deal is the purchase of a stake of less than 10% in Finland’s Klarna, The still-private company...
VALE continues to make progress to becoming a “true corporation”
The ultimate goal is to convert Vale (VALE), the global iron ore producer, into a true corporation from its current status as a company controlled by a shareholder group consisting of Brazilian pension funds, Brazilian bank Bradesco, and Japan’s Mitsui. This...
Two big deals for Cheniere Energy
Cheniere Energy (LNG) has a significant first-mover advantage, I argued upon picking this stock for my Jubak Picks portfolio, since it was the first U.S. company to get a unrestricted permit to export liquified natural gas. Turning that advantage into revenue and...
Adding water play Danaher to my Jubak Picks portfolio
On June 14 I updated my take on why you want water stocks in your portfolio. The sector has entered a new phase, I argued, that made it important for investors to look for water stocks where customers could pay the bill for clean water. Global demand for clean water...
Alibaba blows the top out on growth forecast; raising my target price
Yesterday, June 8, Alibaba (BABA) forecast that revenue would climb by 49% for fiscal 2018. That’s a solid 10 percentage points above the recent projection from Wall Street analysts. The New York traded ADRs climbed almost 10% on the news yesterday....
Deere beats on earnings, raises guidance, soars 7.3% on the day
Before the market open today, Deere (DE) reported fiscal second quarter earning of $2.14 a share. (That excludes the gain from the sale of SiteOne Landscape Supply for $111 million.) Those earnings were 45 cent a share better than the Wall Street consensus of $1.69 a...
Incyte up on positive trial results
Shares of Incyte (INCY) are up 7.1% as of 12:30 p.m. New York time on data released before the June meeting of the American Society of Clinical Oncology showing that Incyte’s epacadostat, which is an IDO inhibitor, has proved effective when used in combination...
Tencent earnings show growth of company’s China media power
Today, May 17, China’s Tencent Holdings(TCEHY)Â reported a 58% increase in first quarter profit on a 55% increase in revenue. The company’s WeChat app is now the world’s third-largest personal messaging app after Facebook’s WhatsApp and...
Cheniere Energy pops on possibility of increased China exports
Earlier this week the Trump administration announced that it had reached an agreement with China to increase market access for U.S. energy companies. Today Cheniere Energy (LNG) noted that it has had extensive negotiations with Chinese state-owned companies about...
New tax proposal knocks back shares of Australian banks including my Dividend Portfolio pick Westpac Banking
The new Australian federal budget includes a 6 basis point (100 basis points equal one percentage point) annual tax on liabilities at the country’s five biggest banks. The tax would apply to liabilities including senior bonds, covered bonds, subordinated bonds...
Freeport McMoRan and Indonesia agree to extend agreement deadline for another 6 months
The stakes are so high that a deal is almost a certainty. Freeport McMoRan Copper and Gold  (FCX) needs the copper production from the giant Grasberg mine, the second largest in the world. The government of Indonesia needs the revenue it gains from Grasberg....
Price is right on Coach acquisition of Kate Spade
The price is right. The strategy makes sense. Now it’s up to the management team at Coach (COH) to execute. Yesterday, May 8, Coach announced that it would buy Kate Spade (KATE) for $18.50 a share. That’s a 27.5% premium on the December 2016 price for the...
Sell Bristol-Myers Squibb before Thursday’s earnings report
I’m selling Bristol-Myers Squibb (BMY) out of my Jubak Picks portfolio ahead of Thursday’s report of first quarter earnings. I’m afraid that earnings will confirm what monthly sales reports from Bristol-Myers and competitors have outlined: That the...
Incyte dropped 10.5% yesterday on FDA drug “rejection”: Here’s what’s actually going on (and why you shouldn’t sell)
I know the headlines on Friday said that the U.S. Food and Drug Administration had “rejected” Olumiant (known more frequently until recently as baricitinib), a new drug for rheumatoid arthritis from Eli Lilly (LLY) and research lead Incyte Corp (INCY.) And...
Samsung’s Galaxy S8 just got less dangerous for Apple
Back on April 3 I pointed to Apple 21 as the next big test for Apple (AAPL) shares. (Apple is a member of my long-term 50 Stocks portfolio.) That’s the date when Samsung’s new Galaxy S8 smartphone will go on sale. The S8 is critical to Samsung–the...
Vale gets a new CEO and gets rid of control by its old shareholders
Vale (VALE) has a new CEO–that’s an important and immediate change. It will take longer to end the control of Vale by a small group of banks and Brazilian state pension funds–until 2020–but that may actually be more important in the long run....Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!